Effects of ciprofibrate on LDL metabolism in man

Atherosclerosis

Volumn 108, Issue 2, 1994, Pages 137-148

  Gaw, A ^a   Packard, C J ^a   Caslake, M J ^a   Griffin, B A ^a   Lindsay, G M ^a   Thomson, J ^a   Vallance, B D ^b   Wosornu, D ^c   Shepherd, J ^a  

^a GLASGOW ROYAL INFIRMARY   (United Kingdom)

^b HAIRMYRES HOSPITAL   (United Kingdom)

^c VICTORIA INFIRMARY   (United Kingdom)

Author keywords

Fibrates; LDL Subfractions; LDL turnover

Indexed keywords

CIPROFIBRATE; LOW DENSITY LIPOPROTEIN;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CLINICAL ARTICLE; HUMAN; HYPERCHOLESTEROLEMIA; LIPOPROTEIN METABOLISM; PRIORITY JOURNAL;

ADULT; AGED; APOLIPOPROTEINS; CLOFIBRATE; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; LIPIDS; LIPOPROTEINS, LDL; MALE; MIDDLE AGE; SUPPORT, NON-U.S. GOV'T;

EID: 0028017562     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/0021-9150(94)90108-2     Document Type: Article

References (37)

1. Fibric acid derivatives
2. The metabolism of low density lipoprotein in familial type II hyperlipoproteinemia
3. Effects of bezafibrate on receptormediated and receptor-independent low density lipoprotein catabolism in type II hyperlipoproteinaemic subjects
4. Identification of multiple subclasses of plasma low density lipoproteins in normal humans
5. Heterogeneity of plasma low density lipoproteins. Manifestations of the physiologic phenomenon in man
6. Rapid isolation of low density lipoprotein (LDL) subfractions from plasma by density gradient ultracentrifugation
7. 131I-labelled plasma proteins
8. CONSAM
9. Evidence for kinetic heterogeneity among low density lipoproteins
10. Kinetics of a heterogeneous population of particles in low density lipoprotein apolipoprotein B
11. Plasma triglyceride and low density lipoprotein metabolism
12. Fenofibrate and LDL metabolic heterogeneity in hypercholesterolaemia
13. Absorption and disposition of 2-[4-(2,2-dichlorocyclopropyl)phenoxyll-2-methyl propanoic acid, WIN 35,833, in rats, monkeys and men
14. Dose-response study of the effect of ciprofibrate on serum lipoprotein concentrations in hyperlipoproteinaemia
15. Longterm efficacy and safety of ciprofibrate in patients with primary hyperlipidemia
16. Ciprofibrate in the therapy of type II hypercholesterolaemia. A double blind trial
17. Longterm treatment with the lipid lowering agent ciprofibrate
18. The recognition and management of hyperlipidaemia in adults: A policy statement of the European Atherosclerosis Society.
19. Receptor-mediated low density lipoprotein catabolism in man
20. Separation of the main lipoprotein density classes from human plasma by ratezonal ultracentrifugation
21. Radioiodination of human low density lipoprotein: a comparison of four methods
22. Protein measurement with the Folin phenol reagent
23. A rapid micromethod for apolipoprotein E phenotyping directly in serum
24. Ultracentrifugal subfractionation of high density lipoprotein
25. The influence of fibrates on lipoprotein metabolism
26. Postprandial lipemia, fenofibrate and coronary artery disease
27. Gemfibrozil improves abnormalities of lipid metabolism in patients on continuous ambulatory peritoneal dialysis: the role of postheparin lipases in the metabolism of high-density lipoprotein subfractions
28. Increase in lipoprotein lipase during clofibrate treatment of hypertriglyceridaemia in patients on hemodialysis
29. Effects of fenofibrate on high and low density lipoprotein metabolism in heterozygous familial hypercholesterolemia
30. Metabolism of apolipoprotein B in large triglyceride-rich very low density lipoproteins of normal and hypertriglyceridemic subjects
31. The influence of apolipoprotein E polymorphism on apolipoprotein B-100 metabolism in normolipemic subjects
32. Effects of bezafibrate on apolipoprotein B metabolism in type III hyperlipoproteinemic subjects
33. Apolipoprotein A and B (Sf 100–400) metabolism during bezafibrate therapy in hypertriglyceridemic subjects
34. Kinetics of LDL subfractions
35. Low-density lipoprotein subclass patterns and risk of myocardial infarction